Founded at the Abramson Cancer Center at the University of Pennsylvania

Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors

Association of Inherited Pathogenic Variants in Checkpoint Kinase 2 (CHEK2) With Susceptibility to Testicular Germ Cell Tumors

JAMA Oncology | 2019

Saud H. AlDubayan; Louise C. Pyle; Marija Gamulin; Tomislav Kulis; Nathanael D. Moore; Amaro Taylor-Weiner; Anis A. Hamid; Brendan Reardon; Bradley Wubbenhorst; Rama Godse; David J. Vaughn; Linda A. Jacobs; Stefanie Meien; Mislav Grgic; Zeljko Kastelan; Sarah C. Markt; Scott M. Damrauer; Daniel J. Rader; Rachel L. Kember; Jennifer T. Loud; Peter A. Kanetsky; Mark H. Greene; Christopher J. Sweeney; Christian Kubisch; Katherine L. Nathanson; Eliezer M. Van Allen; Douglas R. Stewart; Davor Lessel; Regeneron Genetics Center (RGC) Research Team